PHILADELPHIA, May 19, 2015 /PRNewswire/ — GlaxoSmithKline (@GSKUS) today announced the results of an online consumer poll, conducted by Harris Poll on behalf of GSK, of US parents with children ages 16 to 21 years, and young people of the same age range, gauging the knowledge of and attitudes related to meningococcal disease*.
Results from this new, national poll serve as a reminder to parents and high school/college-aged individuals to talk to a healthcare professional to learn if meningococcal disease vaccination is right for them, and determine how to get up to date on vaccinations this summer. US adolescents/young adults are at greater risk for contracting meningococcal disease due to increased likelihood of being in community settings that foster close contact with people (e.g., residence halls, military and other camps).
Key findings of the Harris online poll include:
:: The majority of parents (83%) report wanting their children to be vaccinated against all vaccine-preventable serogroups of bacteria that cause meningococcal disease. The five serogroups of bacteria that cause the overwhelming majority of cases in the US are A, B, C, W-135 and Y.
:: Less than half of parents say they have talked to their child about how the disease is spread (42%) or its early symptoms (38%).
:: Less than half of young people (49%) know that meningococcal disease can lead to serious health complications, which may include hospitalization, hearing loss or amputation.
:: Only about one third of young people (35%) correctly identified college students as a high risk group for the disease. Only 22% know that it is possible to die within 24 hours of early symptoms.
:: Of those parents whose child has been vaccinated against meningococcal disease, 88% don’t know which serogroups of bacteria their child is vaccinated against…